{
    "Symbol": "PAR",
    "ISIN": "INE04LG01015",
    "News": [
        {
            "Title": "PAR Drugs and Chemicals Announces Major Business Restructuring",
            "Summary": "PAR Drugs and Chemicals has announced significant changes to its business structure. The company plans to diversify into real estate and construction, as well as venture into the capital market. Additionally, PAR Drugs and Chemicals will execute a slump sale of its existing establishment for 928.8 million rupees.",
            "Sentiment": "neutral",
            "PublishDate": 1733143394000,
            "Source": "corporate_action"
        },
        {
            "Title": "PAR Drugs and Chemicals Approves Slump Sale and Shifts to Renewable Energy",
            "Summary": "PAR Drugs and Chemicals has approved a slump sale of its existing establishment. The company has also announced its intention to enter the clean, renewable energy business. This marks a significant shift in the company's focus and operations.",
            "Sentiment": "positive",
            "PublishDate": 1733143383000,
            "Source": "corporate_action"
        },
        {
            "Title": "PAR Drugs & Chemicals Schedules Board Meeting for Q2 Results",
            "Summary": "<p><span class='neutral'>PAR Drugs & Chemicals</span> has announced a <b>board meeting</b> scheduled for <span class='neutral'>October 22</span> to <b>consider and approve</b> the company's <span class='neutral'>financial results</span> for the <b>second quarter</b> of the current <span class='neutral'>fiscal year</span>.</p>",
            "Sentiment": "neutral",
            "PublishDate": 1728639468000,
            "Source": "result"
        }
    ]
}